Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis

TBC Silva, PHRF Almeida, VE Araújo… - Therapeutic …, 2018 - journals.sagepub.com
Background: Diabetes mellitus type 1 (DM1) is an autoimmune disease characterized by
metabolic destruction of pancreatic cells responsible for insulin production, with treatment …

Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

D Mayer, E Chantelau - Archives of physiology and biochemistry, 2010 - Taylor & Francis
Context and objective: Insulin glargine (Lantus®) stimulates growth of MCF-7 cells stronger
than human insulin. We investigated if serum from diabetic patients treated with glargine …

[HTML][HTML] Comparison of insulin analogs and human insulins: a narrative review

MS Eledrisi, MIM Danjuma - Journal of Diabetes and Endocrine …, 2023 - thieme-connect.com
Introduction Since insulin analogs have pharmacological properties that are similar to the
normal physiological action of insulin, it has been suggested that they provide better glucose …

[HTML][HTML] Insulin analogs versus human insulins for the management of diabetes: An evidence-based review

MS Eledrisi - Libyan Journal of Medical Sciences, 2020 - journals.lww.com
Insulin analogs are preferred by many physicians over human insulins in the management
of Type 1 diabetes and in patients with Type 2 diabetes who require insulin. Insulin analogs …

[PDF][PDF] Inzulinkezelés–2010

T Gyula, TG Ádám, K Zsuzsa - Körner Anna Az 1-es típusú diabetes … - real-j.mtak.hu
Despite an increase in the number of antihyperglycaemic drugs with different mechanism of
action insulin is the mainstream of diabetes therapy even today. In the last decade new rapid …

[HTML][HTML] Audit de l'équilibre glycémique de patients diabétiques sous analogues de l'insuline: à propos de 2915 assurés de la CNAM (Tunisie)

S Dogui, Y Htira, C Jemai, K Aloui… - La Tunisie …, 2022 - ncbi.nlm.nih.gov
Résumé Introduction: Les analogues de l'insuline sont de plus en plus prescrits en Tunisie.
Ces molécules, prises en charge par la Caisse Nationale d'Assurance Maladie (CNAM) en …

Audit of glycemic control of diabetic patients on insulin analogues: about 2915 insured persons of the CNAM (Tunisia).

S Dogui, Y Htira, C Jemai, K Aloui, W Echater - La Tunisie Medicale, 2022 - europepmc.org
Résumé Introduction: Les analogues de l'insuline sont de plus en plus prescrits en Tunisie.
Ces molécules, prises en charge par la Caisse Nationale d'Assurance Maladie (CNAM) en …

Reduction of glycated hemoglobin (HbA1c) and cost analysis of treatment with insulin analogues in the state of Paraná: a retrospective cohort study.

AC Conegero Sanches, A Wiens… - … Brazilian Journal of …, 2016 - search.ebscohost.com
Objective: Diabetes mellitus (DM) is a serious public health problem in Brazil. The goal of
this study was to evaluate the effectiveness of long-acting insulin analogues in controlling …

[PDF][PDF] Reduction of glycated hemoglobin (HbA

ACC Sanches, A Wiens, MM Garcia… - J Bras Econ …, 2016 - researchgate.net
Objective: Diabetes mellitus (DM) is a serious public health problem in Brazil. The goal of
this study was to evaluate the effectiveness of long-acting insulin analogues in controlling …

[BOOK][B] Patterns of Insulin Use and Hypoglycaemia in the UK: An Epidemiological Study Based on the General Practice Research Database

A Hutchinson - 2014 - search.proquest.com
There have been significant changes in the management of patients with diabetes in the
United Kingdom (UK) over the last 20 years, with the introduction of analogue insulins and …